ReviewFrontiers in pharmacology2026

Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological tools.

Carmela Bonaccorso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.